<DOC>
	<DOCNO>NCT01310764</DOCNO>
	<brief_summary>The purpose study investigate safety efficacy bevacizumab adjunctive treatment trabeculectomy open angle glaucoma patient compare new drug commonly use anti-scarring agent , mitomycin C .</brief_summary>
	<brief_title>Trabeculectomy With Subconjunctival Bevacizumab Injection</brief_title>
	<detailed_description>The common surgical technique control intraocular pressure glaucoma patient trabeculectomy.In surgery , internal cavity eye connect fistula like opening subconjunctival space . The main cause failure trabeculectomy excessive postoperative conjunctival scar site fistula , related severity conjunctival vascularization , tortuousity vessel , fibroblast migration proliferation . At time surgery surgeon use mitomycin C , antimitotic antifibrotic agent , improve result procedure . Although agent effective , without complication . The significant sight threaten complication low intraocular pressure endophthalmitis . Therefore investigation go find much safe effective agent . Bevacizumab monoclonal antibody vascular endothelial factor ( VEGF ) . VEGF important vasculogenic fibrogenic factor prominent role wound healing.Bevacizumab widely use ophthalmology promise effect treatment neovascularization conjunctiva , cornea retina . There limited animal human case series regard effect agent trabeculectomy . In study investigator try , addition evaluate efficacy safety agent result trabeculectomy , compare agent mitomycin C .</detailed_description>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Mitomycin</mesh_term>
	<mesh_term>Mitomycins</mesh_term>
	<criteria>Uncontrolled Open angle glaucoma . Glaucoma patient noncompliant medical treatment . Progressive glaucoma despite medical treatment . Followup least 6 month surgery History prior ocular surgery . Pregnancy breast feeding . Age &lt; 18 year . History ocular surface infection recent two week . History systemic thromboembolic event .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>Intraocular pressure</keyword>
	<keyword>Trabeculectomy</keyword>
	<keyword>Mitomycin C</keyword>
	<keyword>Bevacizumab</keyword>
</DOC>